Table 2 Surgical outcomes of the no occlusion test group (no occlusion group) with conventional surgery and the occlusion test group (occlusion group) with titrated surgery for responders.
From: The role of diagnostic monocular occlusion test in basic type intermittent exotropia
No occlusion group (n = 79) | Occlusion group (n = 136) | p-valuea | Response on occlusion | ||||
---|---|---|---|---|---|---|---|
Responders (n = 99/136) | p-valueb | Non-responders (n = 37/136) | p-valuec | ||||
Surgical outcomes (n, %) | |||||||
Success | 37 (46.8%) | 85 (62.5%) | 0.025* | 65 (65.7%) | 0.012* | 20 (54.1%) | 0.469* |
Recurrence | 39 (49.4%) | 46 (33.8%) | 0.030* | 31 (31.3%) | 0.014* | 15 (40.5%) | 0.374* |
Overcorrection | 3 (3.8%) | 5 (3.7%) | 1.000‡ | 3 (3.0%) | 1.000‡ | 2 (5.4%) | 0.653‡ |
Amount of BLR recession (sum of both muscles, mm) | 12.3 ± 2.1 | 13.0 ± 2.4 | 0.042† | 13.3 ± 2.4 | 0.002† | 11.9 ± 2.1 | 0.293† |
Postoperative deviation (PD) | |||||||
Near | 10.2 ± 9.8 | 9.9 ± 10.3 | 0.879† | 10.3 ± 10.2 | 0.942† | 9.1 ± 10.6 | 0.585† |
Distance | 9.3 ± 8.6 | 7.3 ± 8.6 | 0.098† | 7.5 ± 8.5 | 0.154† | 7.0 ± 9.1 | 0.149† |